Our earlier preview of the seven peptides under FDA review explains what each compound does and why it was nominated.
Clinical evidence demonstrates that L-carnitine supplementation reduces fasting blood glucose (37, 39, 53, 54), insulin levels (54, 55), glycated hemoglobin (HbA1c) (56, 57), and ameliorates insulin resistance (37, 53, 54) in NAFLD patients
For comprehensive healing protocols, many researchers combine GHK-CU with other peptides to address different aspects of tissue repair
Management strategies include ensuring adequate protein intake (1.2-1.6 g/kg ideal body weight daily), maintaining proper hydration, considering dose adjustment or delayed escalation, engaging in regular physical activity, and working with a registered dietitian